Showing results (41-50 of 81) with videos related to

Sort By:
Pageof 9
Journal of Cancer Research and Clinical Oncology|April 20, 2018
A pharmacokinetics and pharmacodynamics equivalence trial of the proposed pegfilgrastim biosimilar, MYL-1401H, versus reference pegfilgrastimCornelius F Waller, Renger G Tiessen, Tracey E Lawrence, et al.
Therapeutic Advances in Medical Oncology|June 9, 2022
Clinical predictors of survival in patients with relapsed/refractory small-cell lung cancer treated with checkpoint inhibitors: a German multicentric real-world analysisJan A Stratmann, Radha Timalsina, Akin Atmaca, et al.
Frontiers in Oncology|September 9, 2020
Immunohistochemistry and Radiomic Features for Survival Prediction in Small Cell Lung CancerEleni Gkika, Matthias Benndorf, Benedict Oerther, et al.
Therapeutic Advances in Medical Oncology|November 25, 2021
Phase III double-blind study comparing the efficacy and safety of proposed biosimilar MYL-1402O and reference bevacizumab in stage IV non-small-cell lung cancerMark A Socinski, Cornelius F Waller, Tazeen Idris, et al.
European Journal of Drug Metabolism and Pharmacokinetics|October 4, 2023
Population Pharmacokinetics of MYL-1402O, a Proposed Biosimilar to Bevacizumab and Reference Product (Avastin<sup>®</sup>) in Patients with Non-squamous Non-small Cell Lung CancerJoel S Owen, Russell J Rackley, Matthew A Hummel, et al.
Clinical Lung Cancer|July 22, 2017
Symptom and Quality of Life Improvement in LUX-Lung 8, an Open-Label Phase III Study of Second-Line Afatinib Versus Erlotinib in Patients With Advanced Squamous Cell Carcinoma of the Lung After First-Line Platinum-Based ChemotherapyEnriqueta Felip, Vera Hirsh, Sanjay Popat, et al.
Acta Haematologica|October 8, 2019
Ponatinib in the Treatment of Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Leukemia: Recommendations of a German Expert Consensus Panel with Focus on Cardiovascular ManagementSusanne Saussele, Wilhelm Haverkamp, Fabian Lang, et al.
Leukemia Research|September 24, 2020
Prevalence and characteristics of myeloproliferative neoplasms with concomitant monoclonal gammopathyNora Rebeka Javorniczky, Julius Wehrle, Gabriele Ihorst, et al.
International Journal of Radiation Oncology, Biology, Physics|March 7, 2025
Impact of Different Mediastinal Staging Modalities on Target Volume Delineation in Locally Advanced Non-Small Cell Lung Cancer: A Secondary Analysis of the Multicenter Randomized PET-Plan TrialAndreas Rimner, Cas Stefaan Dejonckheere, Jörg Sahlmann, et al.
Haematologica|June 2, 2016
Safety and efficacy of ruxolitinib in an open-label, multicenter, single-arm phase 3b expanded-access study in patients with myelofibrosis: a snapshot of 1144 patients in the JUMP trialHaifa Kathrin Al-Ali, Martin Griesshammer, Philipp le Coutre, et al.
Pageof 9